Nant Health

General Information

We are a leading next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. Our unique systems-based approach to personalized healthcare applies novel diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with large-scale, real-time biometric signal and phenotypic data to track patient outcomes and deliver precision medicine. For nearly a decade, we have developed an adaptive learning system, CLINICS, which includes our unique software, middleware and hardware Systems Infrastructure that collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from novel and traditional sources, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.

Employees: 864
Founded: 2010
Contact Information
Address 9920 Jefferson Blvd, Culver City, CA 90230, US
Phone Number (310) 883-1300
Web Address
View Prospectus: Nant Health
Financial Information
Market Cap $1690.2mil
Revenues $66.0 mil (last 12 months)
Net Income $-91.2 mil (last 12 months)
IPO Profile
Symbol NH
Exchange NASDAQ
Shares (millions): 6.5
Price range $14.00 - $14.00
Est. $ Volume $91.0 mil
Manager / Joint Managers Jefferies/ Cowen and Company
CO-Managers First Analysis Securities/ Canaccord Genuity/ FBR
Expected To Trade: 6/2/2016
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change